Scientists develop new method for enzyme immobilization

NewsGuard 100/100 Score

Virtually all processes in the human body rely on a unique class of proteins known as enzymes. To study them, scientists want to attach these molecules to surfaces and hold them fast, but this can often be a tricky undertaking.

Now Jinglin Fu and his colleagues at the Biodesign Institute at Arizona State University have developed a superior method for immobilizing enzymes on surfaces, deftly controlling their orientation, improving their efficiency and rendering them more stable. The group's results appear in today's advanced online issue of PLoS ONE.

Enzymes are essential for the normal functioning of cells, and are involved in tasks including cell regulation, metabolism and signal transduction. They are also necessary for muscle contraction and the transport of ions and other materials throughout the cytoskeleton.

Enzymes like amylases and proteases are central players in the digestive systems of many animals, breaking down starches and other large molecules into smaller parts that can be absorbed by the intestines. Herbivorous animals make use of the enzyme cellulose, to break down plant fiber. "No wonder enzyme function has been a topic of longstanding concern for biochemistry and medicine," says Fu.

Like other proteins, enzymes are composed of linear chains of amino acids. They can range from tens to thousands of amino acids in length. The job of the enzyme is to increase the rate of the desired reaction, without increasing the rate of undesired reactions. Here, a molecule known as the substrate interacts with a given enzyme to produce a product. Without enzymes, many reactions essential to living things could not proceed.

Such catalytic activity has also been adapted and broadly applied in the biomedical arena (especially for various diagnostic testing), as well for industrial applications ranging from photography to the brewing of beer.

Enzymes are also critical for the study of disease. Given their central role in maintaining homeostasis, any single enzyme aberration, including mutation, overproduction, underproduction or deletion can have dire consequences for health. Phenylketonuria, for example, is a disease linked with a single amino acid mutation in the enzyme phenylalanine hydroxylase. If untreated, the condition can lead to mental retardation. Malfunctioning of DNA repair enzymes is associated with a number of forms of cancer.

To properly study enzymes, particularly their catalytic activity, it is necessary to fix them in place on a surface. While researchers have used several techniques for enzyme immobilization, existing methods suffer from several shortcomings. Enzymes need to be properly oriented on the surface with respect to the molecule they are catalyzing in order to work properly. The non-specific binding of proteins can contaminate the reaction and lower or block its efficient progress. Finally, proteins are prone to becoming unfolded and deactivated over time-a process known as denaturation.

In the current study, Fu first generated a high-density array of peptides on a glass slide, each peptide composed of 20 randomly assembled amino acids. A specific enzyme, β galactosidase, was then screened against this array. This method identified two peptides that covalently bound to the enzyme with high affinity, and these were used for the subsequent experiments.

When compared with low-affinity binding peptides and with preexisting surface immobilization techniques, the group found that the high affinity peptides not only were more effective at holding the enzyme in its proper orientation on the slide, they also produced higher specific activity in the enzyme. The enzyme was also less subject to denaturation, compared with controls.

In a further refinement of the technique, the group created mutations of the high affinity peptides, by deleting a single amino acid along the peptide's length and replacing it with a different amino acid. This procedure was repeated with all 20 amino acids in the peptide chain, with the resulting mutations once more screened against the β galactosidase enzyme. The technique, known as single-point variant screening, improved both the binding affinity and specific activity of the bound enzyme.

"This development gives us a new tool, both for enhancing the function of surface bound enzymes, which are of ever-increasing importance to industry, and also for studying the interactions between multiple enzymes in a metabolic pathway," said Neal Woodburry, a co-author of the PLoS ONE study.

Comments

  1. Jone Davies Jone Davies Hong Kong S.A.R. says:

    The enzyme-immobilized carrier material must be effectively combined with the non-catalytic active group of the enzyme to enable the immobilized enzyme to exert its catalytic enzymatic action, and the determination of the carrier material is the key to the immobilization technology of the enzyme. With the continuous advancement of the chemical industry, many new materials with special structures and different functions have been developed, which has promoted the development of carrier immobilized enzyme technology.Creative Enzymes brings cutting-edge technologies to solve the unique demands in your enzyme research. Creative Enzymes performs contract research, through professional and specialized knowledge. In addition to native and recombinant enzymes, we also design and produce artificial enzymes. Our synzymes service include the design and synthetic process as well as the subsequently enzyme activity analysis.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Paxlovid enhances treatment options for COVID-19 patients